Feb 28, 2019 / 04:00PM GMT
Danielle Joy Antalffy - SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior Analyst
Good morning. Oh, can you hear me? Okay. Perfect. Good morning, everyone. Welcome to the SVB Leerink Healthcare Conference. My name is Danielle Antalffy. I am one of the medtech analysts here at SVB Leerink. And we are very lucky to have with us from Johnson & Johnson, Ashley McEvoy. So let me make sure I get your title correct, EVP and Worldwide Chairman of Medical Devices. And also from Investor Relations, we have Chris DelOrefice and also Matthew Stuckley. He will start us off with some of the disclosures.
Matt Stuckley - Johnson & Johnson - VP of IR
Thanks, Danielle. Good morning, everyone. Please be aware that some statements made today may be considered forward-looking or utilize non-GAAP measures. Please refer to our SEC filings, in particular, our 10-K, which discuss the risks and uncertainties around forward-looking statements as well as our website at investor.jnj.com for reconciliations to comparable GAAP measures. Finally, any
Johnson & Johnson at Leerink Partners Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot